Riskx Investments Lowers stake in Cantel Medical Corp. (CMN)

Cantel Medical Corp. (CMN) : Riskx Investments reduced its stake in Cantel Medical Corp. by 4.76% during the most recent quarter end. The investment management company now holds a total of 9,502 shares of Cantel Medical Corp. which is valued at $647,941 after selling 475 shares in Cantel Medical Corp. , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Cantel Medical Corp. makes up approximately 0.55% of Riskx Investments’s portfolio.

Other Hedge Funds, Including , Acadian Asset Management reduced its stake in CMN by selling 161 shares or 98.17% in the most recent quarter. The Hedge Fund company now holds 3 shares of CMN which is valued at $201. Eqis Capital Management sold out all of its stake in CMN during the most recent quarter. The investment firm sold 4,360 shares of CMN which is valued $294,518.Integrated Investment Consultants reduced its stake in CMN by selling 2,454 shares or 55.2% in the most recent quarter. The Hedge Fund company now holds 1,992 shares of CMN which is valued at $134,599. Cantel Medical Corp. makes up approx 0.07% of Integrated Investment Consultants’s portfolio.

Cantel Medical Corp. opened for trading at $68.42 and hit $68.78 on the upside on Thursday, eventually ending the session at $68.21, with a gain of 0.03% or 0.02 points. The heightened volatility saw the trading volume jump to 1,41,305 shares. Company has a market cap of $2,844 M.

On the company’s financial health, Cantel Medical Corp. reported $0.44 EPS for the quarter, beating the analyst consensus estimate by $ 0.08 according to the earnings call on Jun 8, 2016. Analyst had a consensus of $0.36. The company had revenue of $173.70 million for the quarter, compared to analysts expectations of $163.16 million. The company’s revenue was up 22.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.35 EPS.

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy Water Purification and Filtration Healthcare Disposables Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems disinfectants detergents and other supplies. The Company’s Water Purification and Filtration segment includes water purification equipment and services filtration and separation products and disinfectants sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use infection prevention and control healthcare products. The Company’s Dialysis segment includes medical device reprocessing systems sterilants/disinfectants and dialysate concentrates. Its Specialty Packaging segment includes specialty packaging and thermal control products as well as related compliance training.

Leave a Reply

Cantel Medical Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cantel Medical Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.